Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Gel-Coat Biomaterials has raised $1.3M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Gel-Coat Biomaterials's investors include Soken Chemical, WASEDA University Ventures.
Gel-Coat Biomaterials is headquartered in Tokyo, Japan.
Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical technologies.
Gel-Coat Biomaterials is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gel-Coat Biomaterials — Funding & Investors." VCBacked, April 22, 2026, https://www.vcbacked.co/company/gel-coat-biomaterials. Accessed August 14, 2026.
VCBacked. (2026). Gel-Coat Biomaterials — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/gel-coat-biomaterials
{{cite web |title=Gel-Coat Biomaterials — Funding & Investors |url=https://www.vcbacked.co/company/gel-coat-biomaterials |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated